Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 02, 2025 10:00 ET | Source: Cirrus Therapeutics, Inc.

Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD

Cirrus Therapeutics announces $11 million seed financing to advance novel ocular gene therapy to reverse underlying age-related cause of dry AMD.